NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Dalmia Bharat Maintains BUY Rating Despite Earnings Downgrades

Choice Institutional Equities has reaffirmed its BUY rating on Dalmia Bharat, while revising its target price downwards to INR 2,405/share. This decision is based on earnings downgrades of approximately 3.9% for FY27E and 1.9% for FY28E due to increasing input cost pressures driven by geopolitical uncertainty.

The company's management has guided for a cost increase of INR 125-150 per ton in Q1FY27 compared to Q4FY26. This rise is primarily attributed to packaging costs (INR 80-90 per ton), with the remaining impact stemming from logistics and power & fuel expenses. Despite the company's efforts to implement price hikes, with further increases expected, Choice Institutional Equities estimates a net cost escalation of approximately INR 80 per ton, which is likely to exert mild pressure on EBITDA per ton in FY27E.

Revised Target Price and Valuation Framework

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The revised target price of INR 2,405/share is based on an Enterprise Value to Cash Earnings (EV/CE) valuation framework. In this framework, a multiple of 1.6x is assigned for FY28E.

RecommendationFY27E Earnings DowngradeFY28E Earnings Downgrade
Dalmia Bharat3.9%1.9%
Source: Choice Institutional Equities

This revised target price reflects the current market conditions and the company's anticipated performance in the coming years.

Investor Takeaway

Investors should consider buying Dalmia Bharat with a target price of Rs 2405.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.